Robert Pignolo, MD
Internal Medicine · Rochester, MNNPI 1558302315
Payments from drug & device makers
Across 550 payments — averaging $3603.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$587K
- Incyte Corporation$533K
- Ipsen Innovation$393K
- Ipsen Bioscience Inc.$220K
- GSK$131K
- Ipsen Biopharmaceuticals, Inc$85K
- plus $33K from 3 others
Across 24 payments — averaging $271.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$7K
What the payments were for
- Consulting fees$4,3258%
- Speaking & faculty fees$37,12571%
- Travel & lodging$5,18810%
- Food & beverage$3391%
- Education$5,00010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 51 | $587,177 |
| Incyte Corporation | 315 | $533,228 |
| Ipsen Innovation | 96 | $393,052 |
| Ipsen Bioscience Inc. | 43 | $219,675 |
| GSK | 2 | $130,690 |
| Ipsen Biopharmaceuticals, Inc | 27 | $84,769 |
| Ipsen Pharma SAS | 14 | $33,147 |
| Daiichi Sankyo Inc. | 1 | $50 |
| Ipsen Biopharm Limited | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sohonos$22,099
How this compares
$1,981,813 in reported general payments places this provider in the 95th percentile of 1,924 internal medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Rochester
- Gregory PolandRochester$494K
- Ryan HurtRochester$187K
- Paul DanielsRochester$145K
- Jody OlsonRochester$66K
- Luke SeaburgRochester$65K
- Ekta KapoorRochester$55K
- Bradley SalonenRochester$38K
- Ilya ShadrinRochester$35K
- Brian JonesRochester$34K
- Sandhya PruthiRochester$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.